Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
Intermittent preventive treatment (IPT) is used to reduce malaria morbidity and mortality, especially in vulnerable groups such as children and pregnant women. IPT with the fixed dose combination of piperaquine (PQ) and dihydroartemisinin (DHA) is being evaluated as a potential mass treatment to con...
Principais autores: | Permala, J, Tarning, J, Nosten, F, White, N, Karlsson, M, Bergstrand, M |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
American Society for Microbiology
2017
|
Registros relacionados
-
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
por: Chotsiri, P, et al.
Publicado em: (2019) -
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
por: Palang Chotsiri, et al.
Publicado em: (2019-01-01) -
Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
por: Bergstrand, M, et al.
Publicado em: (2014) -
Efficacy and safety of dihydroartemisinin-piperaquine.
por: Myint, H, et al.
Publicado em: (2007) -
Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
por: Lwin, K, et al.
Publicado em: (2012)